Table 1.
Group | Case (n=15) |
Sex | Age (years old) |
History of internal malignancy |
Histology | MSH-2/ MLH-1 |
---|---|---|---|---|---|---|
A | 1A | m | 48 | yes | s. adenoma | −/+ |
2A | f | 43 | yes | s. adenoma | −/+ | |
3A | m | 67 | no | s. adenoma | −/+ | |
4A | m | 91 | no | s. adenoma | +/+ | |
5A | m | 78 | no | s. adenoma | +/+ | |
B | 1B | m | 48 | yes | s. carcinoma | +/+ |
2B | m | 90 | no | s. carcinoma | +/+ | |
3B | f | 81 | no | s. carcinoma | +/+ | |
4B | f | 84 | no | s. carcinoma | +/+ | |
C | 1C | m | 56 | yes | sebaceoma | −/+ |
2C | m | 58 | yes | sebaceoma | undiagnostic | |
3C | m | 58 | yes | sebaceoma | −/+ | |
4C | f | 82 | no | sebaceoma | +/+ | |
5C | m | 66 | no | sebaceoma | +/+ | |
6C | m | 77 | unknown | sebaceoma | undiagnostic |
A, sebaceous adenoma; B, sebaceous carcinoma; C, sebaceoma
* (−), loss of staining for MSH-2/MLH-1; (+), presence of nuclear immunoreactivity for MSH-2/ MLH-1
* cases 1a and 1b, 1c and 3c, 4b and 4c corresponded to same patients